Lupus Virtual Provider Education Series: All Activities
Lupus Virtual Provider Education Series: All Activities is organized by American College of Rheumatology (ACR).
Start Date: Monday, April 19, 2021, 12:00 AM
End Date: Friday, April 19, 2024, 11:55 PM
Description:
Assess your rheumatology medical knowledge and enhance your patient care. With the Lupus Virtual Provider Education Series you receive:
• 7 online educational activities, multiple-choice questions with in-depth answer rationales
• Activity topics include recognizing the signs and symptoms of lupus, lab testing, lupus flares, lupus nephritis, lupus and pregnancy, laboratory testing, medications management, and preventative care and maintenance.
• 7 AMA PRA Category 1 Credits™ with a passing score of 80% or higher
Learning Objectives:
Upon completion of this activity, participants should be able to:
• Identify the presenting signs and symptoms of lupus, with a special focus on presentations and prevalence in minority populations
• Utilize the ACR's criteria for classification of SLE to evaluate and refer a potential lupus patient to a rheumatologist
• Facilitate co-management of a lupus patient with his/her rheumatologist, with special attention to mediation adherence, monitoring for adverse effects, and laboratory and symptom monitoring, especially in situations where the rheumatologist is geographically distant
• Identify and manage lupus-specific preventative care concerns, including vaccinations, cardiovascular health, fertility, and long-term consequences of medications
Activity 1 - What Is Lupus?
Upon completion of this activity, participants should be able to:
• Identify classic and atypical presentations of lupus, focusing on patient signs and symptoms and physical examination findings
• Discuss with patients and with peers the differential diagnosis of patients presenting with symptoms that may suggest lupus
• Highlight high-yield lupus-specific questions when taking a patient history and review of systems to help refine the differential diagnosis
• Describe the demographics of lupus and highest-risk populations for lupus complications
Activity 2 - Laboratory Testing in Lupus
Upon completion of this activity, participants should be able to:
• Identify and understand lab studies typically sent when evaluating a new patient with lupus.
• Utilize the ACR Lupus Classification Criteria and understand its limitations in the clinical setting
• Appreciate the clinical nature of a lupus diagnosis, understanding that laboratory testing represents only one of several components necessary for diagnosis
Activity 3 - Medications in Lupus
Upon completion of this activity, participants should be able to:
• Implement the general approach to medications in lupus, using a few case studies to illustrate prescribing patterns
• Identify the role corticosteroids play in morbidity in Systemic Lupus Erythematosus (SLE) and know situations where increasing corticosteroids may or may not be beneficial
• Create strategies to assist with medication access for the uninsured or underinsured
Activity 4 - Identifying and Managing Lupus Flares
Upon completion of this activity, participants should be able to:
• Recognize signs and symptoms that may indicate a lupus flare.
• Utilize high-yield lupus-specific questions and physical examination findings to help confirm a lupus flare or make a lupus flare less likely
• Identify high acuity signs and symptoms that may warrant hospital admission
Activity 5 - Special Topics in Lupus
Upon completion of this activity, participants should be able to:
• Utilize basic treatment paradigms for lupus nephritis
• Distinguish between proliferative and membranous lupus nephritis
• Recognize classic dermatologic manifestations of lupus
• Identify important considerations for lupus in pediatric populations, including chronic steroid exposure, bone • health, medication dosing, and transition to adult care
Activity 6 - Lupus in Pregnancy
Upon completion of this activity, participants should be able to:
• Utilize important considerations for fertility and family planning in patients with lupus including medication considerations, lupus activity, and hypercoagulability
• Identify antiphospholipid antibody syndrome and its implications in patients desiring pregnancy
• Identify the role of SSA and SSB antibodies in neonatal congenital cardiac conditions
• Recognize neonatal lupus
Activity 7 - Health Maintenance and Preventative Care Considerations in Lupus
Upon completion of this activity, participants should be able to:
• Explain the risk factors for premature coronary artery disease in lupus patients and risk modification strategies
• Recognize osteoporosis risk factors and its treatment considerations in women of childbearing age
• Identify appropriate immunization schedules for lupus patients and understand contraindications to immunization among patients on immunosuppressive medications